Sanofi Agrees to Acquire US-based mRNA Developer ‘Translate Bio’
According to the reports, the company ‘Sanofi’ has agreed for acquiring ‘Translate Bio’ as biotech company based in the United States in a deal of 3.2 billion dollars as Sanofi has now been betting on the next-generation mRNA vaccine technology beyond the novel corona virus pandemic. The company ‘Sanofi’ said, it is going to be […]
Continue Reading